Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model

Full text
Author(s):
Favaro, Wagner J. [1] ; Socca, Eduardo A. R. [1] ; Bockelmann, Petra K. [1] ; Reis, Ianny B. [1] ; Garcia, V, Patrick ; Duran, Nelson [2, 3]
Total Authors: 6
Affiliation:
[1] Univ Campinas UNICAMP, Dept Struct & Funct Biol, Lab Urogenital Carcinogenesis & Immunotherapy, Ave Bertrand Russell S-N, BR-13083865 Campinas, SP - Brazil
[2] Fed Univ ABC UFABC, Nanomed Res Unit NANOMED, Santo Andre, SP - Brazil
[3] Garcia, Patrick, V, Univ Campinas UNICAMP, Dept Struct & Funct Biol, Lab Urogenital Carcinogenesis & Immunotherapy, Ave Bertrand Russell S-N, BR-13083865 Campinas, SP - Brazil
Total Affiliations: 3
Document type: Journal article
Source: MEDICAL ONCOLOGY; v. 39, n. 2 FEB 2022.
Web of Science Citations: 0
Abstract

This work describes the effects of immunotherapy with Protein Aggregate Magnesium-Ammonium Phospholinoleate-Palmitoleate Anhydride in the treatment of non-muscle invasive bladder cancer in an animal model. NMIBC was induced by treating female Fischer 344 rats with N-methyl-N-nitrosourea. After treatment with MNU, the rats were distributed into four experimental groups: Control (without MNU) group, MNU (cancer) group, MNU-BCG (Bacillus Calmette-Guerin) group, and MNU-P-MAPA group. P-MAPA intravesical treatment was more effective in histopathological recovery from cancer state in relation to BCG treatment. Western blot assays showed an increase in the protein levels of c-Myc, COUP-TFII, and wild-type p53 in P-MAPA-treated rats in relation to BCG-treated rats. In addition, rats treated with P-MAPA intravesical immunotherapy showed the highest BAX protein levels and the lowest proliferation/apoptotic ratio in relation to BCG-treated rats, pointing out a preponderance of apoptosis. P-MAPA intravesical treatment increased the wild-type p53 levels and enhanced c-Myc/COUP-TFII-induced apoptosis mediated by p53. These alterations were fundamental for histopathological recovery from cancer and for suppress abnormal cell proliferation. This action of P-MAPA on apoptotic pathways may represent a new strategy for treating NMIBC. (AU)

FAPESP's process: 14/11866-1 - Mechanisms and effects of the immunomodulator P-MAPA in the treatment of prostate cancer and non-muscle invasive bladder cancer: interfaces between energy metabolism, oxidative balance, angiogenesis and signaling pathway of toll-like receptors
Grantee:Petra Karla Böckelmann
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 12/13585-4 - EFFECTS OF INTRAVESICAL IMMUNOTHERAPIES WITH BCG AND P-MAPA ON SEXUAL STEROID HORMONES RECEPTORS AND REACTIVE OXYGEN SPECIES: POTENTIAL THERAPEUTIC STRATEGIES FOR URINARY BLADDER CANCER
Grantee:Patrick Vianna Garcia
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 11/05726-4 - Oxidative Stress, Antioxidant Enzyme Activities and Toll-Like Receptors 2 and 4 Signaling Pathway in Urinary Bladder Cancer Progression of Rats Submitted to Bacillus Calmette-Guerin and P-MAPA Intravesical Immunotherapies.
Grantee:Fábio Rodrigues Ferreira Seiva
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 12/20706-2 - New therapeutic strategies for non-muscle invasive bladder cancer: effects of BCG and P-mapa immunotherapies on the steroid hormone receptors and reactive oxygen species
Grantee:Wagner José Fávaro
Support Opportunities: Regular Research Grants